Twist Bioscience Corporation (1TWST)
MTA
169.25
-7.55 (-4.27%)
Closed
Oct 2, 2026
Day's Range
169.25172.70
52 wk Range
21.70177.40
Financial Statements - 1TWST - Twist Bioscience Corporation
Revenue
376.57M▲ 39.8%
Net Income
-77.67M▲ 56.8%Net Margin -20.6%
EBITDA
-160.25M▼ 41.3%
Free Cash Flow
-75.63M▼ 27.1%
Income Statement
| Period Ending | 2025-09-30 | 2024-09-30 |
|---|---|---|
| Sales | 376.57M | 269.31M |
| Cost of Goods | 185.57M | 154.56M |
| Gross Profit | 191M | 114.74M |
 Operating Expense | - | - |
| Operating Income | -136.25M | -151.36M |
| Non-Operating Interest | - | - |
| Other Income Expense | 47.94M | -40.94M |
| Pre Tax Income | -76.95M | -179.12M |
| Income Tax | 719K | 481.87K |
| Net Income | -77.67M | -179.60M |
| EPS Basic | -1.3 | -3.6 |
| EPS Diluted | -1.3 | -3.6 |
| Basic Shares Outstanding | 59.80M | 49.92M |
| Diluted Shares Outstanding | 59.80M | 49.92M |
| Ebit | -136.25M | -179.10M |
| Ebitda | -160.25M | -113.39M |
| Net Income Continuous Operations | -77.67M | -179.60M |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
